Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  A ALIMENTARY TRACT AND METABOLISM
    A05 BILE AND LIVER THERAPY
      A05A BILE THERAPY
        A05AA Bile acids and derivatives [DG:DG01956]
          A05AA02 Ursodeoxycholic acid
            D00734  Ursodiol (USP) <JP/US>

USP drug classification [BR:br08302]
  Gastrointestinal Agents
    Gastrointestinal Agents, Other
      Ursodiol
        D00734  Ursodiol (USP)

Therapeutic category of drugs in Japan [BR:br08301]
  2  Agents affecting individual organs
    23  Digestive organ agents
      236  Cholagogues
        2362  Bile acids
          D00734  Ursodiol (USP); Ursodeoxycholic acid (JP19/INN)

Classification of Japanese OTC drugs [BR:br08313]
  Agents for digestive organs
    11 Stomachics
      D00734  Ursodiol (USP)
    13 Digestives
      D00734  Ursodiol (USP)
    14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators
      D00734  Ursodiol (USP)

Risk category of Japanese OTC drugs [BR:br08312]
  Third-class OTC drugs
    Inorganic and organic chemicals
      Ursodeoxycholic acid
        D00734  Ursodiol (USP)

Drug groups [BR:br08330]
  Gastrointestinal agent
    DG01956  Bile acid preparation
      D00734  Ursodiol

Target-based classification of drugs [BR:br08310]
  Nuclear receptors
    Thyroid hormone like receptors
      Liver X receptor like receptor
        NR1H4 (FXR) [HSA:9971] [KO:K08537]
          D00734  Ursodiol (USP) <JP/US>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D00734  Ursodeoxycholic acid
    D00734  Ursodeoxycholic acid tablets
    D00734  Ursodeoxycholic acid granules